Submit Deal

CARDEA BIO

Summary

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.

Deals Overview

Total Deals2

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Sort

cardea bio

HQ - United States

Biotechnology

2 May 2023

Investment Date

100%

Stake

n/a

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy